All In Biotech

Drug Trial Radar · NCT06054919

The Effect of Vitamin D3 Therapy on Vitamin D Status in Pregnant Women With Vitamin D Deficient and Insufficient

The Effect of Vitamin D3 Therapy on 25(OH)D, 1,25(OH)2D, VDBP, and 24,25(OH)2D Maternal Serum Levels in Pregnant Women With Vitamin D Deficient and Insufficient

Last checked: Nov 20, 2026Latest source record: Sep 26, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

52

Actual

Start

Apr 1, 2021

Primary completion

Nov 30, 2023

Study completion Nov 30, 2023

Sponsor

Lead sponsor
Universitas IndonesiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 26, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a randomized controlled trial which compares the effect of vitamin D3 therapy 5,000 IU daily and 50,000 IU on 25(OH)D and 1,25(OH)2D, VDBP, and 24,25(OH)2D maternal serum levels in pregnant women with vitamin D deficient and insufficient.

Conditions

  • Vitamin D Deficiency

Interventions

  • CholecalciferolDrug

    vitamin D3

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 25(OH)D maternal serum levelTime frame: 4 weeks after intervention
  2. 1,25(OH)2D maternal serum levelTime frame: 4 weeks after intervention
  3. VDBP maternal serum levelTime frame: 4 weeks after intervention
  4. 24,25(OH)2D maternal serum levelTime frame: 4 weeks after intervention

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cipto Mangunkusumo National Center General Hospital

    Jakarta Pusat, DKI Jakarta, Indonesia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.